Literature DB >> 19429848

Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.

Hubert H Fernandez1, Reiner H See, Matthew F Gary, Dawn Bowers, Ramon L Rodriguez, Charles Jacobson, Michael S Okun.   

Abstract

Consecutive patients in a Movement Disorders Center with Parkinson disease (PD) were offered to undergo complete neuropsychological testing and to complete the Beck Depression Inventory (BDI), regardless of their cognitive and behavioral status. A total of 82 patients were included in this cross-sectional study and had a mean age of 67.7 years, formal education of 14.8 years, PD duration of 101 months, Unified Parkinson Disease Rating Scale-Motor ''off'' score of 36.96, Mini-Mental State Examination (MMSE) score of 27.8 (range 19-30), and BDI score of 10.23 (SD 8.65). Beck Depression Inventory scores did not correlate with disease duration or motor scores but inversely correlated with the MMSE scores (r = -0.40; P < .001) and total Dementia Rating Scale (DRS) scores (r = -0.33; P < .01). Using a univariate regression analysis controlling for age, gender, education, and total Unified Parkinson Disease Rating Scales (UPDRS) score, the BDI scores had a significant and unique relationship with MMSE scores. However, when the BDI scores were correlated with specific cognitive domains, only the Boston Naming Test and the Hopkins Verbal Learning Test (HVLT) delayed recall remained significant after Bonferroni correction. Similarly, when comparing the cognitive performance of patients with PD who scored >14 on the BDI versus those who scored <14, only the mean score of the Boston Naming Test was different between the 2 groups. Our study shows that while depressive symptoms correlated with global cognitive performance, naming, verbal memory, and language are the most susceptible cognitive domains affected with depressive symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19429848     DOI: 10.1177/0891988709335792

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  10 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

2.  Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.

Authors:  Roseanne D Dobkin; Alexander I Tröster; Jade Tiu Rubino; Lesley A Allen; Michael A Gara; Margery H Mark; Matthew Menza
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

3.  Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Authors:  G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz
Journal:  Alzheimers Dement       Date:  2012-11-16       Impact factor: 21.566

4.  Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.

Authors:  Sarah M Szymkowicz; Vonetta M Dotson; Jacob D Jones; Michael S Okun; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

5.  Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease.

Authors:  Danny Bega; Sheng Luo; Hubert Fernandez; Kelvin Chou; Michael Aminoff; Sotirios Parashos; Harrison Walker; David S Russell; Chadwick W Christine; Rohit Dhall; Carlos Singer; Ivan Bodis-Wollner; Robert Hamill; Daniel Truong; Zoltan Mari; Sofya Glazmann; Meilin Huang; Emily Houston; Tanya Simuni
Journal:  Mov Disord Clin Pract       Date:  2015-07-14

Review 6.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

Review 7.  Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?

Authors:  Julia Heller; Imis Dogan; Jörg B Schulz; Kathrin Reetz
Journal:  Aging Dis       Date:  2013-10-22       Impact factor: 6.745

8.  The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism.

Authors:  Adrianus L A J Hommel; Marjan J Meinders; Stefan Lorenzl; Richard Dodel; Miguel Coelho; Joaquim J Ferreira; Brice Laurens; Umberto Spampinato; Wassilios Meissner; Kristina Rosqvist; Jonathan Timpka; Per Odin; Michael Wittenberg; Bas R Bloem PhD; Raymond T Koopmans; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2020-05-21

9.  Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease?

Authors:  Christina Tremblay; Oury Monchi; Carol Hudon; Joël Macoir; Laura Monetta
Journal:  Parkinsons Dis       Date:  2012-02-12

10.  Cognitive Function in Parkinson's Disease Patients with and without Anxiety.

Authors:  K A Ehgoetz Martens; J Y Y Szeto; A J Muller; J M Hall; M Gilat; C C Walton; S J G Lewis
Journal:  Neurol Res Int       Date:  2016-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.